Kunkel Lori Anne
Reporting owner on Forms 3, 4 and 5, CIK 1536368.
Kunkel Lori Anne reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-03.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ELVN · Enliven Therapeutics, Inc.CIK 1672619 | director | 1 | 2026-11-03 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ELVN · Enliven Therapeutics, Inc.Common Stock | 2026-10-30 | M exercised | +3,741 | $1.12 | 45,625 | Form 4 |
| ELVN · Enliven Therapeutics, Inc.Common Stock | 2026-10-30 | M exercised | +7,300 | $18.3 | 52,925 | Form 4 |
| ELVN · Enliven Therapeutics, Inc.Stock Option (right to buy), derivative | 2026-10-30 | M exercised | -3,741 | $0 | 0 | Form 4 |
| ELVN · Enliven Therapeutics, Inc.Stock Option (right to buy), derivative | 2026-10-30 | M exercised | -7,300 | $0 | 30,582 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001536368-26-000008 | Enliven Therapeutics, Inc. | 2026-11-03 |